Cassava Sciences Inc.

NASDAQ: SAVA · Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Aug 15, 2025, 3:59 PM
2.33
-0.85%
After-hours: Aug 15, 2025, 07:46 PM EDT

Cassava Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a -1.8K n/a
Cost of Revenue
n/a 1.53M 1.3M 534K
Gross Profit
n/a -89.42M -1.3M -534K
Operating Income
-24.34M -105.96M -80.02M -32.87M
Interest Income
8.51M 7.83M 2.78M 49K
Pretax Income
-24.34M -97.22M -76.25M -32.38M
Net Income
-24.34M -97.22M -72.47M -31.8M
Selling & General & Admin
71.81M 16.53M 11.99M 8.05M
Research & Development
69.64M 89.42M 68.03M 24.81M
Other Expenses
n/a -89.42M 997K 434K
Operating Expenses
141.45M 105.96M 80.02M 32.87M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 105.96M 80.02M 32.87M
Income Tax Expense
n/a n/a -3.77M -583K
Shares Outstanding (Basic)
46.33M 41.93M 40.2M 39.41M
Shares Outstanding (Diluted)
46.6M 41.93M 40.2M 39.41M
EPS (Basic)
-0.53 -2.32 -1.8 -0.81
EPS (Diluted)
-0.52 -2.32 -1.8 -0.81
EBITDA
-23.21M -95.69M -74.94M -31.85M
EBIT
-24.34M -97.22M -76.25M -32.38M
Depreciation & Amortization
1.13M 1.53M 1.3M 534K